120 related articles for article (PubMed ID: 10551739)
1. Immunohistochemical evaluation of Fhit protein expression in oral squamous cell carcinomas.
van Heerden WF; Swart TJ; van Heerden MB; van Rensburg EJ; Engelbrecht S; Dreyer L; Huebner K
J Oral Pathol Med; 1999 Nov; 28(10):433-7. PubMed ID: 10551739
[TBL] [Abstract][Full Text] [Related]
2. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):584-6. PubMed ID: 15897145
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of PTEN and FHIT in oral squamous cell carcinoma and their relations with cyclin D1].
Shen LJ; Xie SM; Yin C; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):79-82. PubMed ID: 15684005
[TBL] [Abstract][Full Text] [Related]
5. Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera.
van Heerden WF; Swart TJ; van Heerden MB; Pekarsky Y; Sutherland R; Huebner K
Anticancer Res; 2001; 21(4A):2419-23. PubMed ID: 11724301
[TBL] [Abstract][Full Text] [Related]
6. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
[TBL] [Abstract][Full Text] [Related]
7. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
Yutori H; Semba S; Komori T; Yokozaki H
Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):812-4. PubMed ID: 16027075
[TBL] [Abstract][Full Text] [Related]
9. FHIT RNA and protein expression in oral squamous cell carcinomas.
van Heerden WF; Swart TJ; Robson B; Smith TL; Engelbrecht S; van Heerden MB; van Rensburg EJ; Huebner K
Anticancer Res; 2001; 21(4A):2425-8. PubMed ID: 11724302
[TBL] [Abstract][Full Text] [Related]
10. Loss of FHIT expression in squamous cell carcinoma and premalignant lesions of the larynx.
Yuge T; Nibu K; Kondo K; Shibahara J; Tayama N; Sugasawa M
Ann Otol Rhinol Laryngol; 2005 Feb; 114(2):127-31. PubMed ID: 15757192
[TBL] [Abstract][Full Text] [Related]
11. [Expression of FHIT and MDM2 in oral submucous fibrosis and canceration tissues].
Yin X; Wen C; Han Y; Gao Y; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):572-5. PubMed ID: 20622329
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
[TBL] [Abstract][Full Text] [Related]
13. Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer.
Paradiso A; Ranieri G; Stea B; Zito A; Zehbe I; Tommasino M; Grammatica L; De Lena M
Int J Oncol; 2004 Feb; 24(2):249-55. PubMed ID: 14719099
[TBL] [Abstract][Full Text] [Related]
14. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
[TBL] [Abstract][Full Text] [Related]
15. Multiple molecular alterations of FHIT in betel-associated oral carcinoma.
Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC
J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493
[TBL] [Abstract][Full Text] [Related]
16. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
17. Abnormal fragile histidine triad expression in advanced cervical cancer and evaluation of its utility as a prognostic factor.
Machida S; Ohwada M; Saga Y; Suzuki M
Oncology; 2003; 65(1):89-93. PubMed ID: 12837987
[TBL] [Abstract][Full Text] [Related]
18. [Correlation of FHIT expression to cell proliferation and metastasis of laryngeal squamous cell carcinoma].
Yin DT; Lu XB; Dong MM; Qiu XG; Wang QZ
Ai Zheng; 2004 Nov; 23(11):1338-41. PubMed ID: 15522186
[TBL] [Abstract][Full Text] [Related]
19. [HPV detection and FHIT expression in esophageal squamous carcinoma from high incidence area in Cixian County].
Liu YL; Li XM; Jin GL; Yan X; Yang JZ; Wang JL; Li YH; Wang FR; Zhang XH
Ai Zheng; 2003 May; 22(5):492-5. PubMed ID: 12753709
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma.
Wakulich C; Jackson-Boeters L; Daley TD; Wysocki GP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 May; 93(5):573-9. PubMed ID: 12075207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
